Apelec SRL
2.6 FTEThe score of Apelec shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +24 % Total assets +3 % Headcount (avg FTE) +44 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apelec's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 12 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jun 2024
- Year ended 31 Dec 2022filed on 16 Jun 2023
- Year ended 31 Dec 2021filed on 10 Jun 2022
Apelec's financial analysis
- Solvency60.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apelec
Apelec's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0451.379.404
- VAT number
- BE0451379404
- Peppol
- Registered · 0208:0451379404 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Dec 1993
- Registered office
- 1982 Zemst
- Size
- Micro · 2.6 FTE
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apelec (SRL) has been based in Zemst since 1993, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 86,493 € and equity of €1.06m; its revenue is not published. With 2.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 60.8%, above the median of its sector (44.2%).
Companies similar to Apelec
Companies in the same business, of comparable size and area, outside its group.
- Inge Thoelen Retail sale of pharmaceutical products Landen · balance sheet €1.74m
- Mooy Pharma Retail sale of pharmaceutical products Veurne · balance sheet €1.74m
- Apotheek Hasseltsepoort Retail sale of pharmaceutical products Diest · balance sheet €1.74m
- Den Baksteen Retail sale of pharmaceutical products Asse · balance sheet €1.73m
- Pharmacie Charue Retail sale of pharmaceutical products Fleurus · balance sheet €1.76m
- Hampharma Retail sale of pharmaceutical products Tessenderlo-Ham · balance sheet €1.75m
- Pharma City 2 Retail sale of pharmaceutical products Brussels · balance sheet €1.72m
- Selvais Retail sale of pharmaceutical products Bastogne · balance sheet €1.75m
Frequently asked questions about Apelec
What is the revenue of Apelec?
Apelec files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apelec?
In Belgium, the VAT number is the company number prefixed with BE: BE0451379404 for Apelec, if the company is VAT-registered. Its company number (CBE) is 0451.379.404.
Where is the registered office of Apelec?
According to the CBE register, the registered office of Apelec is in 1982 Zemst.
What is the equity of Apelec?
At the close of the 2025 financial year, the equity of Apelec amounts to 1,056,255 €, a solvency of 60.8% of total assets.
How many people work at Apelec?
2.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Apelec?
The register lists 4 active mandates at Apelec. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apelec
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →